Congressman Greg Landsman highlights legislative efforts and economic concerns in recent statements

Congressman Greg Landsman highlights legislative efforts and economic concerns in recent statements
U.S. Rep. Greg Landsman Serving Southwest Ohio — Facebook Website
0Comments

Congressman Greg Landsman, who represents Ohio’s 1st district since 2023, has been vocal on current economic and social issues through recent statements on social media. His comments critique the current economic strategies and highlight legislative efforts aimed at healthcare affordability.

In a statement posted on April 2, 2025, Congressman Landsman expressed his concern about the state of the economy, noting, “This is more chaos. No plan. No strategy. No investments in American manufacturing. No investment in American workers. Prices will go up and the economy will continue to falter. Pure chaos.”

On April 3, 2025, he announced the reintroduction of legislative efforts regarding insulin costs. He stated, “Every family should be able to afford their child’s insulin. Today, we reintroduced the Making Insulin Affordable for All Children Act to cap insulin costs at $35/month for kids and young adults. No parent should have to choose between buying groceries and buying insulin.”

Later the same day, Landsman addressed the economic challenges attributed to previous administrative decisions. He commented, “We have to focus on the results of Trump’s chaos Prices are going up Economy is tanking People may lose their healthcare and Social Security.”



Related

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA

How many companies in cities in Hamilton County received FDA inspections in Q1?

There were four companies in a city associated with Hamilton County that received four FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA cites Givaudan Flavors Corporation in Cincinnati with 1 violation during Feb. 13 inspection

During a Feb. 13 inspection at Givaudan Flavors Corporation in Cincinnati, the FDA assessed food composition, standards, labeling, economic practices, and foodborne biological hazards, resulting in one citation.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA conducts April 16 inspection at Cincinnati Eye Bank for Sight Restoration

On April 16, the FDA carried out an inspection focused on human cellular, tissue, and gene therapy operations at Cincinnati Eye Bank for Sight Restoration, LLC in Cincinnati, as reflected in the FDA’s publicly available data.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Cincy Reporter.